Maryland-based Advarra has acquired YourEncore, a provider of drug development and commercialization services in Indianapolis. Advarra, which specializes in regulatory review solutions and clinical site technologies, did not disclose the financial terms of the deal.
“Together, we will advance our shared vision of accelerating the drug development lifecycle and the delivery of life-saving therapies to patients,” said Gadi Saarony, chief executive officer of Advarra. “YourEncore brings a well-respected team of industry professionals that—when combined with our IRB and IBC reviews and technology solutions—enables sites and sponsors to optimize clinical research, solve regulatory challenges, and ensure quality and compliance.”
Advarra says its consulting services support biopharmaceutical companies, device manufacturers, academic medical centers, health systems, and institutions in nearly 60 countries.
“Advarra and YourEncore are a great fit, and I’m thrilled to see the continued commitment to our deep-seated expertise and our three centers of excellence practices,” said Brad Lawson, co-founder and chief executive officer of YourEncore. “Our experts are driven by a passion to improve the lives of patients worldwide and I’m excited to see the impact that increased opportunities and complementary offerings create when YourEncore combines forces with Advarra.”
Advarra says YourEncore’s life sciences expertise will help support the company’s ability to offer technology and tools to advance clinical research.